CANY
XYL icon

Caxton Associates (New York)’s Xylem XYL Stock Holding History

Caxton Associates (New York)’s Portfolio XYL Stock Details XYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-9,865
Closed -$771K – 706
2022
Q2 		$771K Buy
9,865
+1,742
+21% +$144K 0.07% 183
2022
Q1 		$693K Buy
+8,123
New +$778K 0.06% 169
2020
Q1 		– Sell
-33,701
Closed -$2.65M – 614
2019
Q4 		$2.65M Buy
+33,701
New +$2.62M 0.36% 41
2017
Q4 		– Sell
-50,000
Closed -$3.13M – 553
2017
Q3 		$3.13M Sell
50,000
-30,000
-38% -$1.79M 0.11% 162
2017
Q2 		$4.43M Buy
+80,000
New +$4.17M 0.17% 140

Other funds holding XYL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Caxton Associates (New York)'s XYL Position: Q3 2022 in Review

Caxton Associates (New York) sold out of Xylem (XYL) in Q3 2022, closing a stake of 9,865 shares — an estimated $771K sold.

Caxton Associates (New York) first reported a position in XYL in Q2 2017 and held it in 5 quarters. The position peaked at $4.43M in Q2 2017. 740 funds tracked by Wall St. Rank hold XYL as of Q3 2022.

  • Caxton Associates (New York) reported no remaining Xylem position as of Q3 2022 after selling out during the quarter.
  • Caxton Associates (New York) sold 9,865 Xylem shares in Q3 2022, an estimated $771K.
  • Caxton Associates (New York) first reported a position in Xylem in Q2 2017 and held it in 5 quarters.
  • Caxton Associates (New York)'s Xylem position peaked at $4.43M in Q2 2017.
  • 740 funds tracked by Wall St. Rank held Xylem as of Q3 2022.

Based on Caxton Associates (New York)'s 13F filing for Q3 2022, filed 14 Nov 2022.